Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30
Rhea-AI Summary
Co-Diagnostics (NASDAQ:CODX), a molecular diagnostics company, announced its participation in the virtual Lytham Partners Fall 2025 Investor Conference on September 30, 2025. The company will deliver a webcast presentation at 4:15 p.m. ET and conduct one-on-one meetings with institutional investors.
The presentation will be accessible through the conference website and will be available for replay afterward. Investors can find the presentation slides on the company's investor relations website and schedule one-on-one meetings through Lytham Partners.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CODX declined 7.05%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.1% during that session. Argus tracked a trough of -7.4% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $1M from the company's valuation, bringing the market cap to $17M at that time.
Data tracked by StockTitan Argus on the day of publication.
Company Webcast
The Company presentation will take place today at 4:15 p.m. ET, and can be accessed by visiting the conference home page at https://lythampartners.com/fall2025/ or directly at https://app.webinar.net/bwLr50QqD7v. The webcast will also be available for replay following the event. The slide deck used in the presentation can be found on https://ir.co-dx.com/.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/fall2025invreg/.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-participate-in-the-lytham-partners-fall-2025-investor-conference-on-september-30-302570821.html
SOURCE Co-Diagnostics